Wellington Partners Unveils €210m Eurocentric Biotech/Medtech Fund WPLS-V

 
• By Mike Ward

With its WPLS-IV fund now fully committed, Wellington Partners has returned to the market and raised €210m in its WPLS-V fund which will focus on European biotech and medtech opportunities.

Euro currency
Wellington Closes Oversubscribed Fifth Generation Fund • Source: Shutterstock

More from Financing

More from Business